<DOC>
	<DOC>NCT00414973</DOC>
	<brief_summary>The purpose of this study is to compare the effect of injectable teriparatide to intranasal salmon calcitonin on lumbar spine bone mineral density, in the treatment of Chinese patients with established osteoporosis</brief_summary>
	<brief_title>A Study for Patients With Osteoporosis</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Salmon calcitonin</mesh_term>
	<mesh_term>Teriparatide</mesh_term>
	<mesh_term>Calcitonin</mesh_term>
	<mesh_term>Calcitonin Gene-Related Peptide</mesh_term>
	<criteria>Clinical diagnosis of osteoporosis No other severe disabling conditions Should have at least 1 vertebral or nonvertebral prevalent fracture, and bone mineral density Tscore should be less than 2.5 Ambulatory Men (aged 40 to 85 years) or postmenopausal women (aged 55 to 85 years) History of a disease that affects bone metabolism History of treatment with any drug that may significantly affect bone metabolism History or presence of liver disease History or presence of kidney disease History of excessive alcohol drinking or drug abuse</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>